H-CRGDKGPDC-OH

CAS: 1392278-76-0

Ref. 3D-PH00060

Produktinformation

• Name: H-CRGDKGPDC-OH
• Synonyme: H-Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys-acid iRGD

Beschreibung

Peptide H-CRGDKGPDC-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CRGDKGPDC-OH include the following: RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions H Javid , MA Oryani , N Rezagholinejad- Cancer ..., 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.6800 for enhanced fluorescence visualization of glioblastoma tumors based on HPMA copolymers conjugated with tumor targeting and/or cell-penetrating peptides E Grosmanová, R Pola, M Filipová, M Henry, JL Coll - View, 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/VIW.20230116 Isolation of Primary Hepatocytes for Testing Tumor Penetrating Peptides E Savier, P Tuffery, H Bruzzoni-Giovanelli- Cell Penetrating Peptides ..., 2022 - Springerhttps://link.springer.com/protocol/10.1007/978-1-0716-1752-6_26 One-pot synthesis of functional peptide-modified gold nanoparticles for gene delivery X Xu, Y Liu, Y Yang, J Wu, M Cao, L Sun - Colloids and Surfaces A ..., 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S092777572200245X Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma B Paul, RH Gaonkar , D Dutta , R Dasi , B Mukherjee - Biomaterials ..., 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0928493122000741 Using peptides to promote delivery and improve anti-tumour efficacy of liposomal drug JG Altin, Y Zhao - Journal of Drug Targeting, 2022 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/1061186X.2021.2020799 Recent progress in functional peptides designed for tumor-targeted imaging and therapy XY Wang , YH Wang, Z Song, XY Hu, JP Wei- Journal of Materials ..., 2021 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2021/tc/d0tc05405d Tumor penetrating peptide-functionalized tenascin-C antibody for glioblastoma targeting P Lingasamy , AH Laarmann- Current cancer drug ..., 2021 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ccdt/2021/00000021/00000001/art00006 Nanoparticles modified with vasculature-homing peptides for targeted cancer therapy and angiogenesis imaging E Seyyednia , F Oroojalian , B Baradaran - Journal of controlled ..., 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365921004582 68Ga-labeling of internalizing RGD (iRGD) peptide functionalized with DOTAGA and NODAGA chelators D Satpati, K Vats, R Sharma- Journal of Peptide ..., 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3241 Fluorescent RGD-based pro-apoptotic peptide conjugates as mitochondria-targeting probes for enhanced anticancer activities SFA Rizvi , S Mu, Y Wang, S Li, H Zhang - Biomedicine & Pharmacotherapy, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0753332220303711 In vivo tumor gene delivery using novel peptideticles: pH-responsive and ligand targeted core-shell nanoassembly M Alipour , A Majidi , F Molaabasi - journal of cancer, 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31577 Design of an amphiphilic iRGD peptide and self-assembling nanovesicles for improving tumor accumulation and penetration and the photodynamic efficacy of the Y Jiang, X Pang, R Liu, Q Xiao , P Wang- applied materials & ..., 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsami.8b11699 Peptide-decorated polymeric nanomedicines for precision cancer therapy H Sun , Y Dong, J Feijen , Z Zhong - Journal of controlled release, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365918305686 Peptides for tumor-specific drug targeting: State of the art and beyond M Roveri, M Bernasconi , JC Leroux - Journal of Materials ..., 2017 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2017/tb/c7tb00318h Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy Y Huang, X Li, H Sha, L Zhang, X Bian- Oncology ..., 2017 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/or.2017.5440 iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice W Qifan, N Fen, X Ying, F Xinwei, D Jun, Z Ge - Tumor Biology, 2016 - Springerhttps://link.springer.com/article/10.1007/s13277-016-4961-x iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes L Simón-Gracia , H Hunt, P Scodeller , J Gaitzsch - Biomaterials, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961216303544 Coupling Gd-‘DTPA with a bispecific, recombinant protein anti-‘EGFR-‘iRGD complex improves tumor targeting in MRI X Xin, H Sha, J Shen, B Zhang , B Zhu- Oncology ..., 2016 - spandidos-publications.comhttps://www.spandidos-publications.com/or/35/6/3227 Tumor-penetrating iRGD peptide inhibits metastasis KN Sugahara, GB Braun , TH de Mendoza - Molecular cancer ..., 2015 - AACRhttps://aacrjournals.org/mct/article-abstract/14/1/120/130571 Increasing tumor accessibility with conjugatable disulfide-bridged tumor-penetrating peptides for cancer diagnosis and treatment VR Kotamraju, S Sharma, P Kolhar - Cancer: Basic and ..., 2015 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.4137/BCBCR.S29426 Enhancing accumulation and penetration of HPMA copolymer-doxorubicin conjugates in 2D and 3D prostate cancer cells via iRGD conjugation with an MMP-2 ZH Peng , J Kopecek - Journal of the American Chemical Society, 2015 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jacs.5b00922 Targeting peptide iRGD-conjugated amphiphilic chitosan-co-PLA/DPPE drug delivery system for enhanced tumor therapy X Nie, J Zhang, Q Xu, X Liu, Y Li, Y Wu- Journal of Materials ..., 2014 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2014/tb/c3tb21744b Amphipathic tail-anchoring peptide is a promising therapeutic agent for prostate cancer treatment G De, JK Ko , T Tan, H Zhu , H Li , J Ma - Oncotarget, 2014 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202157/ Near-infrared Dye® 800CW-conjugated disulfide-based cyclic RGD peptide c (CRGDKGPDC) and its DOTA analog A Chopra - 2012 - europepmc.orghttps://europepmc.org/books/nbk100265 Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging Y Ye, L Zhu , Y Ma, G Niu , X Chen - Bioorganic & medicinal chemistry letters, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0960894X10018767 Near-infrared Dye® 800CW-conjugated disulfide-based cyclic RGD peptide c (CRGDKGPDC) and its DOTA analog Ac-Cys (IRDye800CW)-iRGD and DOTA-Cys A Chopra - europepmc.orghttps://europepmc.org/books/n/micad/cys800cwirgd/?extid=20641640&src=med

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 948.04 g/mol
• Formel: C₃₅H₅₇N₁₃O₁₄S₂